AVE 0.00% 0.3¢ avecho biotechnology limited

pre announce, page-35

  1. 215 Posts.
    "It's pretty clear though that the product is intended to "treat" mastitis as an alternative to antibiotics."

    This statement is not quite correct by my interpretation. I read that it is intended to treat sub-clinical mastitis as an alternative to antibiotics. Not active, clinical, mastitis. i.e. not therapeutic.

    There is a big difference between sub-clinical mastitis and clinical mastitis.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $88 35K

Buyers (Bids)

No. Vol. Price($)
53 94188418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 75939351 20
View Market Depth
Last trade - 11.18am 03/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.